Status:
COMPLETED
Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Henoch-Schoenlein Purpura
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Henoch-Schonlein purpura is a leucocytoclastic systemic vasculitis involving small vessels with the deposition of immune complexes containing IgA. It is characterized by the association of skin, joint...
Detailed Description
The protocol test the role of 2 modalities of treatment (steroid vs. steroid and cyclophosphamide) for severe systemic form of Henoch-Schonlein purpura. The severe forms include extracapillary glomeru...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with Henoch-Schoenlein purpura
- Patient's age \> 18 years
- Exclusion criteria:
- Patient presenting a purpura RHEUMATOID the diagnosis of which is confirmed by the histology presenting at least a visceral infringement(achievement) making consider the affection as engraves(burns)
- of 18 or more years old Patient
- Patient capable of understanding(including) the advantages and the risks of the try
- Patient having given his assent lit in writing
Exclusion
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00190229
Start Date
September 1 2002
End Date
January 1 2008
Last Update
May 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital LARIBOISIERE
Paris, France, 75015